These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 5824739)

  • 21. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.
    Sabin MA; De Hora M; Holly JM; Hunt LP; Ford AL; Williams SR; Baker JS; Retallick CJ; Crowne EC; Shield JP
    Pediatrics; 2007 Dec; 120(6):e1426-33. PubMed ID: 18055661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental obesity in man. VI. The effect of variations in intake of carbohydrate on carbohydrate, lipid, and cortisol metabolism.
    Sims EA; Bray GA; Danforth E; Glennon JA; Horton ES; Salans LB; O'Connell M
    Horm Metab Res; 1974; Suppl 4():70-7. PubMed ID: 4423813
    [No Abstract]   [Full Text] [Related]  

  • 23. Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons.
    Glueck CJ; Levy RI; Fredrickson DS
    Ann Intern Med; 1971 Sep; 75(3):345-52. PubMed ID: 5568147
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
    Aubry F; Lapierre YL; Noël C; Davignon J
    Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial hyper-pre-betalipoproteinemia with observations on the metabolism of endogenous particles.
    Rose HG
    J Lab Clin Med; 1970 Jul; 76(1):92-102. PubMed ID: 5425367
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia.
    Glueck CJ
    Metabolism; 1971 Jul; 20(7):691-702. PubMed ID: 5090133
    [No Abstract]   [Full Text] [Related]  

  • 27. Pediatric familial type IV hyperlipoproteinemia.
    Glueck CJ; Tsang R; Fallat R; Ford S; Evans G; Beckett D; Steiner P
    Trans Assoc Am Physicians; 1972; 85():139-50. PubMed ID: 4660006
    [No Abstract]   [Full Text] [Related]  

  • 28. Type IV hyperlipoproteinaemia. A survey based on 23 cases.
    Christensen NC; Horder M
    Dan Med Bull; 1970 Feb; 17(2):54-9. PubMed ID: 5446368
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mid term tolerance to low fat, high carbohydrate diet in hyperlipemia (or hyperglyceridemia)].
    de Gennes JL; Truffert J; Labrousse B
    Ann Med Interne (Paris); 1972 Jan; 123(1):1-13. PubMed ID: 5051240
    [No Abstract]   [Full Text] [Related]  

  • 30. A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance.
    Wardle EN; Menon IS; Anderson J
    Q J Med; 1972 Jan; 41(161):15-23. PubMed ID: 5070986
    [No Abstract]   [Full Text] [Related]  

  • 31. Xanthomata in primary hyperlipoproteinemia. A classification based on the lipoprotein pattern of the blood.
    Polano MK; Baes H; Hulsmans HA; Querido A; Pries C; van Gent CM
    Arch Dermatol; 1969 Oct; 100(4):387-400. PubMed ID: 5358101
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and treatment of hyperlipoproteinemias].
    Hauser J; Pometta D
    Schweiz Med Wochenschr; 1972 Feb; 102(8):265-70. PubMed ID: 5010516
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipid changes after fasting in obese patients].
    Schrub JC; Joly JP; Wolf LM; Courtois H; Matray P; Rousseau PY; Brunelle P
    Sem Hop; 1973 Apr; 49(19):1349-56. PubMed ID: 4355381
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hyperlipoproteinemias. I].
    Weber K; Braun-Falco O
    Hautarzt; 1971 Dec; 22(12):517-20. PubMed ID: 4945742
    [No Abstract]   [Full Text] [Related]  

  • 35. The hyperlipidemia in glycogen storage disease.
    Jakovcic S; Khachadurian AK; Hsia DY
    J Lab Clin Med; 1966 Nov; 68(5):769-79. PubMed ID: 5223987
    [No Abstract]   [Full Text] [Related]  

  • 36. The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease.
    Salel AF; Riggs K; Mason DT; Amsterdam EA; Zelis R
    Am J Med; 1974 Dec; 57(6):897-903. PubMed ID: 4378395
    [No Abstract]   [Full Text] [Related]  

  • 37. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on primary hyperlipoproteinemia. 3. Disturbances of carbohydrate metabolism].
    Ciświcka-Sznajderman M
    Pol Arch Med Wewn; 1971 May; 46(5):577-83. PubMed ID: 5566930
    [No Abstract]   [Full Text] [Related]  

  • 39. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects.
    Herranz L; Zapata A; Grande C; Megia A; Pallardo LF
    Horm Metab Res; 1998 Mar; 30(3):141-5. PubMed ID: 9566856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diurnal patterns of plasma triglycerides and free fatty acids in normal subjects and in patients with endogenous (type IV) hyperlipoproteinemia.
    Schlierf G; Reinheimer W; Stossberg V
    Nutr Metab; 1971; 13(2):80-91. PubMed ID: 5123770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.